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Abstract
Background: HIV prevalence and incidence among sexually active women in peri-urban areas of Ladysmith, Edendale, and
Pinetown, KwaZulu-Natal, South Africa, were assessed between October 2007 and February 2010 in preparation for vaginal
microbicide trials.
Methodology/Principal Findings: Sexually active women 18–35 years, not known to be HIV-positive or pregnant were
tested cross-sectionally to determine HIV and pregnancy prevalence (798 in Ladysmith, 1,084 in Edendale, and 891 in
Pinetown). Out of these, approximately 300 confirmed non-pregnant, HIV-negative women were subsequently enrolled at
each clinical research center (CRC) in a 12-month cohort study with quarterly study visits. Women in the cohort studies were
required to use a condom plus a hormonal contraceptive method. HIV prevalence rates in the baseline cross-sectional
surveys were high: 42% in Ladysmith, 46% in Edendale and 41% in Pinetown. Around 90% of study participants at each CRC
reported one sex partner in the last 3 months, but only 14–30% stated that they were sure that none of their sex partners
were HIV-positive. HIV incidence rates based on seroconversions over 12 months were 14.8/100 person-years (PY) (95% CI
9.7, 19.8) in Ladysmith, 6.3/100 PY (95% CI 3.2, 9.4) in Edendale, and 7.2/100 PY (95% CI 3.7, 10.7) in Pinetown. The 12-month
pregnancy incidence rates (in the context of high reported contraceptive use) were: 5.7/100 PY (95% CI 2.6, 8.7) in
Ladysmith, 3.1/100 PY (95% CI 0.9, 5.2) in Edendale and 6.3/100 PY (95% CI 3.0, 9.6) in Pinetown.
Conclusions/Significance: HIV prevalence and incidence remain high in peri-urban areas of KwaZulu-Natal.
Citation: Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, et al. (2012) HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three
Districts. PLoS ONE 7(4): e35278. doi:10.1371/journal.pone.0035278
Editor: Ruanne V. Barnabas, University of Washington, United States of America
Received January 14, 2012; Accepted March 15, 2012; Published April 19, 2012
Copyright:  2012 Nel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: No current external funding sources for this study.
Competing Interests: Jian Wu is a consultant (JW consulting is a one person business) and was paid to conduct the statistical analyses for this paper. This does
not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: j.vandewijgert@amc-cpcd.org
Introduction
The South African province of KwaZulu-Natal is experiencing
one of the worst HIV epidemics worldwide. The epidemic has
been described as hyperendemic, generalized and mature, with
HIV prevalence rates in the general population of over 15% [1–5].
Data from the Department of Health antenatal surveys and the
Human Sciences Research Council (HSRC) cross-sectional
population-based household surveys have shown a stabilization
of prevalence rates since 2005 [3–5]. HIV prevalence is expected
to increase in the context of a mature epidemic with increasing
access to antiretroviral therapy because people living with HIV
will survive longer [6,7]. Therefore, HIV incidence data are
increasingly important because only data on new HIV infections
will provide insight into ongoing transmission dynamics [6,7].
KwaZulu-Natal is divided into 11 districts. The HIV epidemics
in two of these districts have been extensively studied: the urban
district of eThekwini (Durban Metropolitan Area and surrounding
area) and the rural district of uMkhanyakude (where the Africa
Centre of the University of KwaZulu-Natal is located) [8–11].
Recent studies in these districts found HIV incidence rates of 6.4/
100 person-years (PY) among urban women and 6.5/100 PY
among rural women aged 14–30 years [8] and 3.6/100 PY among
rural women aged 15–55 [11]. Our research was conducted in
eThekwini district (in the small town of Pinetown, about 16 km
west of Durban) and in two under-researched districts of
KwaZulu-Natal: Ladysmith, the capital city of the uThukela
district, and Edendale (near Pietermaritzburg) in the uMgungun-
dlovu district. All three study areas can be characterized as peri-
urban. According to the 2009 and 2010 antenatal surveys, the
HIV prevalence rates in pregnant women in eThekwini,
uThukela, and uMgungundlovu districts were 41.4/41.1%,
46.4/36.7%, and 40.9/42.3%, respectively [3,4].
We conducted HIV prevalence and incidence studies in sexually
active women in the above-mentioned peri-urban areas of
KwaZulu-Natal to better understand how many and where new
HIV infections are occurring and to assess the feasibility of
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35278undertaking vaginal microbicide trials for HIV prevention in these
populations.
Methods
Study design and populations
In preparation for future vaginal microbicide trials for HIV
prevention in KwaZulu-Natal, cross-sectional studies (targeting
800–1,000 women each) were conducted at three clinical research
centers (CRC) to determine HIV prevalence and to identify HIV-
negative, non-pregnant women for enrollment in subsequent
cohort studies (targeting 300 women each). The main aim of the
cohort studies was to determine HIV incidence in seroconversions
per 100 PY. The CRCs were located in Ladysmith, Edendale, and
Pinetown. Each CRC established a Community Advisory Group
(CAG) to provide community input in study procedures and to
assist the researchers with community education and mobilization.
CRC staff, with the assistance of CAG members, organized
meetings in public spaces (at public meetings, in shopping centers
and in waiting areas of clinics), where the study was presented.
Women who expressed an interest in study participation were then
invited to visit the CRC for screening and possible enrollment. In
addition, door-to-door or family visits were conducted by study
staff. While the recruitment strategies were CRC-specific, the
same study procedures were followed at each CRC from the
moment women were screened for study participation.
Women were eligible for the cross-sectional studies if they were
18–35 years, not HIV-positive or pregnant by self-report, not
breastfeeding, and sexually active (defined as at least one
penetrative vaginal coital act per month for the previous three
months). Women who tested HIV- and pregnancy-negative in the
cross-sectional studies, still met the entry criteria described above,
and met additional entry criteria for the cohort studies, were
subsequently offered enrollment into the cohort studies. These
additional entry criteria included using a condom plus a hormonal
(oral or injectable) contraceptive method [12], not injecting non-
therapeutic drugs, not participating in other studies, not suffering
from specified chronic diseases or allergies, refraining from anal
sex and planning to stay in the study area for the duration of the
study. Follow-up visits were scheduled at 3, 6, 9 and 12 months.
At all study visits, women were interviewed regarding
demographics, sexual behavior, vaginal hygiene practices, and
medical history; and received HIV risk reduction and contracep-
tive counseling, condoms, and syndromic management of sexually
transmitted infections (STI) free of charge [13]. Confirmed HIV-
positive women were referred for HIV care, and pregnant women
were referred for antenatal care. HIV-positive and pregnant
women enrolled in the cohort studies could continue study
participation if so desired. The study was approved by two ethical
review committees in South Africa: the University of Witwaters-
rand Human Research Ethics Committee and Pharma-Ethics.
Formal support for the study was also obtained from provincial,
district, hospital and clinical authorities, and from local commu-
nity leaders. Written informed consent was obtained from all study
participants.
Laboratory testing
An HIV testing algorithm was used to determine the presence of
prevalent and incident HIV infections. Women were first tested by
OraQuick ADVANCE Rapid HIV-1/2 Antibody Test using oral
swabs (OraSure Technologies Inc., Bethlehem, PA, USA) or by
Uni-Gold Recombigen HIV test using blood (Trinity Biotech,
Bray, Wicklow, Ireland). When this first HIV test was positive,
blood samples were tested by Determine HIV-1/2 rapid test
(Inverness Medical Professional Diagnostics, Princeton, NJ, USA),
and by enzyme-linked immunosorbant assay (ELISA) if a
tiebreaker was needed. Blood samples from women who were
confirmed HIV-positive were also tested by BED assay (Calypte
Biomedical Corporation, Portland, OR, USA) according to the
manufacturer’s instructions. A specimen with a final normalized
optical density value of less than or equal to 0.8 was considered to
be from a participant who was infected less than 155 days before
[14]. Urine samples from each participant were tested for
pregnancy using an hCG pregnancy test.
Data Analysis and Statistics
Case report forms were processed using the DataFax data
management system (Clinical DataFax Systems Inc., Hamilton,
Ontario, Canada) and analyzed using SAS version 9.2 (SAS
Institute, Cary, NC, USA). Descriptive statistics were used to
summarize baseline demographic, behavioral and clinical charac-
teristics. Categorical variables were expressed as percentages, and
continuous data as medians with inter-quartile ranges.
Incidence rates in the cohort studies were calculated based on a
Poisson distribution with PY at risk in the denominator. A person’s
time at risk began at the enrollment visit and ended at the last
study visit attended (usually the Month 12 visit) or when HIV
infection or pregnancy occurred. HIV infection and pregnancy
were assumed to have occurred at the mid-point between the last
available negative test and first positive test. A woman who
reached an HIV endpoint was no longer considered at risk for
HIV but was still considered at risk for pregnancy, and vice versa.
HIV incidence rates and 95% confidence intervals based on BED
results in the cross-sectional studies were calculated using the
formula, and accompanying spreadsheet, provided by McWalter
and Welte [15,16]. Inputs in the formula include the total number
of HIV-positive and HIV-negative individuals in the sample, the
number of HIV-positive individuals who also tested positive on the
BED assay, the BED window period, and an estimated BED false-
recent rate (FRR). A recent study in KwaZulu-Natal found a local
FRR of 1.7% [17] and a study in Zimbabwe a window period of
187 days (instead of the 155 days that are specified in the package
insert) [18]. Two BED adjustments were therefore made: one
using a window period of 155 days and a FRR of 1.7%, and
another one using a window period of 187 days and a false recent
rate of 1.7%. Incidence estimates are expressed as an incidence
rate (number of new HIV infections per 100 PY).
Age-adjusted and multivariable logistic regression models were
used to assess predictors of prevalent HIV infection and
pregnancy, with p-values from the Wilcoxon-Mann-Whitney test
for continuous variables and the Chi-square and Fisher’s exact
tests for categorical variables. Age-adjusted Cox proportional
hazards regression models were used to assess predictors of HIV
seroconversion and incident pregnancy.
Results
Disposition
Women were enrolled in the cross-sectional studies between
2007 and 2009 as follows: 798 women in Ladysmith, 1,084 women
in Edendale, and 891 women in Pinetown. The Ladysmith and
Edendale CRCs subsequently enrolled 300 women in their cohort
studies and the Pinetown CRC 297 women, accumulating 223,
254, and 223 PY respectively. In Ladysmith, 129 of 300 (43%)
participants completed all scheduled visits; 53 women withdrew
early from the cohort study, 32 were lost to follow-up, and none
died. In Edendale, 210 of 300 (70%) participants completed all
scheduled visits; 6 women withdrew early from the cohort study,
HIV Incidence Kwazulu-Natal, South Africa
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Ladysmith Edendale Pinetown
Characteristic n (%) N=798 N=1,084 N=891
Age in years (median; range) 24 (18–35) 24 (18–35) 23 (18–35)
Race: Black African 792 (99.2) 1,081 (99.7) 890 (99.9)
Marital status
Single 723 (90.6) 988 (91.1) 799 (89.7)
Married/or living together 75 (9.4) 90 (8.3) 91 (10.2)
Separated/divorced/widowed 0 6 (0.6) 1 (0.1)
Education
No school 2 (0.3) 5 (0.5) 3 (0.3)
Some/completed primary school 26 (3.3) 40 (3.6) 81 (9.1)
Some/completed high school 651 (81.6) 1,002 (92.5) 748 (84.3)
Some/completed tertiary school 119 (14.9) 36 (3.3) 55 (6.2)
Source of income
1
Formal/informal work 193 (24.2) 56 (5.2) 123 (13.8)
Government grants 321 (40.2) 639 (59.1) 509 (57.2)
Husband/partner 95 (11.9) 25 (2.3) 78 (8.8)
Other 471 (59.0) 397 (36.7) 234 (26.3)
Average monthly income
0-R500 542 (67.9) 1034 (95.7) 772 (86.6)
.R500 256 (32.1) 47 (4.3) 119 (13.4)
Male sex partners in last 3 months
1 718 (90.0) 998 (92.1) 780 (87.5)
2 or more 80 (10.0) 86 (7.9) 111 (12.5)
Male sex partners in last 7 days
0 152 (19.9) 215 (19.9) 135 (15.2)
1 608 (79.5) 859 (79.3) 750 (84.4)
2 or more 5 (0.7) 9 (0.8) 4 (0.4)
Condom used during last sex act 374 (46.9) 577 (53.2) 550 (62.0)
Condom use in last 7 day
2
Always 228 (35.5) 404 (42.2) 322 (42.2)
Inconsistent 197 (30.7) 137 (14.3) 182 (23.9)
Never 217 (33.8) 416 (43.5) 259 (33.9)
Any chance that any current sex partner is HIV-positive
Yes 210 (26.3) 178 (16.7) 182 (20.5)
No 235 (29.5) 187 (17.5) 125 (14.1)
Don’t know 352 (44.2) 702 (65.8) 579 (65.3)
Ever had anal sex 4 (0.5) 28 (2.6) 3 (0.3)
Ever had oral sex 115 (14.4) 169 (15.6) 145 (16.3)
Ever vaginal cleansing before or after sex 8 (1.0) 20 (1.8) 67 (7.6)
Ever vaginal drying before or after sex 1 (0.1) 16 (1.5) 37 (4.1)
Self assessment of HIV risk
3
No/low risk 392 (51.4) 449 (42.2) 407 (50.1)
Moderate risk 58 (7.6) 188 (17.7) 20 (2.5)
High risk 312 (40.9) 426 (40.1) 385 (47.4)
Reported genital symptom at baseline
4 34 (4.3) 15 (1.4) 27 (3.0)
1Multiple responses allowed.
2Women who reported any sexual intercourse in the last 7 days only.
3Women who said ‘don’t know’ were excluded.
4Includes lower abdominal pain, genital discharge, odor, ulcers, sores, itching or swelling, burning pain on urination.
doi:10.1371/journal.pone.0035278.t001
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(56%) participants completed all scheduled visits; 5 women
withdrew early from the cohort study, 74 were lost to follow-up,
and none died.
Demographic and behavioral characteristics
In the cross-sectional studies, the median age of study
participants was 23 or 24 years (Table 1). Almost all participants
were black African, and more than 80% at each CRC was single,
had only one sexual partner in the last 3 months, and had at least
some high school education. About half of the participants (47–
62%) had used a condom during their last sex act, while only 14–
30% was sure that they did not currently have a sex partner who
was HIV-positive. Anal sex was rarely reported at each CRC
(,3%), but oral sex was more common (14–16%). Women in
Pinetown were more likely to report cleansing or drying the vagina
before or after sex (8% and 4%, respectively) than women in
Ladysmith and Edendale. Less than 4% of all women reported a
genital symptom. At each CRC, demographic and sexual behavior
characteristics of cohort study participants at enrollment were
Table 2. Age-adjusted Determinants of Prevalent HIV Infection in the Cross-Sectional Studies
1.
Determinant Ladysmith (N=798) Edendale (N=1,084) Pinetown (N=891)
%H I V +
Age-adjusted OR
(95% CI) % HIV+
Age-adjusted OR




Married/living together 48.0 0.8 (0.5, 1.3) 60.0 1.0 (0.6, 1.5) 53.3 1.2 (0.8, 2.0)
Single, separated or divorced (reference) 41.4 44.8 39.9
Highest level of education achieved:
Some/completed primary education 50.0 2.9 (1.2, 7.4) 70.0 9.1 (2.9, 28.9) 54.3 6.2 (2.5, 15.1)





Formal/informal work (reference) 53.9 48.2 44.2
Government grants 36.4 0.6 (0.4, 0.9) 52.1 1.2 (0.7, 2.1) 46.8 1.1 (0.7, 1.7)
Husband/Other 39.4 0.9 (0.6, 1.3) 35.9 1.0 (0.5, 1.8) 30.7 0.9 (0.5, 1.4)
Average monthly income
5
0-R500 (reference) 40.2 45.8 42.5
.R500 45.7 0.8 (0.6, 1.1) 51.1 1.1 (0.6, 2.0) 33.3 0.5 (0.3, 0.8)
Number of sex partners in last 3 months
1 (reference) 40.7 46.3 40.1
More than 1 53.8 1.9 (1.2, 3.2) 43.0 1.2 (0.7, 1.9) 49.5 1.7 (1.1, 2.6)
Condom use in last 7 days
Always (reference) 27.2 32.4 32.5
Inconsistent 50.3 2.5 (1.7, 3.8) 58.1 2.6 (1.7, 4.0) 48.6 1.9 (1.3, 2.8)
Never 47.5 2.1 (1.4, 3.1) 56.7 2.4 (1.8, 3.3) 50.8 1.8 (1.3. 2.6)
Ever had oral sex
2
Yes 43.5 1.0 (0.7, 1.6) 43.8 1.0 (0.7, 1.4) 41.7 1.1 (0.7, 1.5)
No (reference) 41.7 46.4 41.2
Self assessment of HIV risk
No/low risk (reference) 24.7 25.2 26.8
Moderate risk 53.4 3.6 (2.0, 6.4) 58.3 3.8 (2.6, 5.6) 60.0 3.0 (1.2, 7.7)
High risk 58.7 4.1 (3.0, 5.8) 61.5 3.9 (2.9, 5.3) 53.3 2.9 (2.1, 3.9)
Any chance that any current sex partner is HIV+
Yes 51.0 3.2 (2.1, 4.9) 62.4 4.7 (2.9, 7.8) 51.1 2.6 (1.6, 4.3)
No (reference) 23.4 20.9 27.2
Don’t know 49.1 3.0 (2.0, 4.3) 48.2 3.1 (2.0, 4.6) 41.6 1.8 (1.2, 2.8)
Reported genital symptom at baseline
Yes 55.9 1.9 (0.9, 4.0) 46.7 1.1 (0.4, 3.2) 70.4 4.2 (1.7, 10.2)
No (reference) 41.4 46.1 40.4
1Each row represents one bivariable model including age and the predictor of interest.
2Anal sex, vaginal cleansing and vaginal drying were too infrequently reported to be assessed as a predictor of HIV prevalence (see Table 1).
doi:10.1371/journal.pone.0035278.t002
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the cohort than in cross-sectional studies felt that they were at high
risk for HIV (25% vs. 41% in Ladysmith, 22% vs. 40% in
Edendale, and 31% vs. 47% in Pinetown). Furthermore, women
enrolled in the cohort in Edendale reported more condom use
during the last sex act than those enrolled in the cross-sectional
study (69% vs. 53%).
Condom use dynamics
More than 80% of women at all three CRCs reported that they
themselves, or they and their partner together, decided about
condom use (data not shown). About one third of women (28% in
Ladysmith, 16% in Edendale, and 39% in Pinetown) reported to
have refused sex in the last 7 days due to lack of a condom. The
most common reasons for using a condom were ‘to protect myself
from HIV’ (49% in Ladysmith, 74% in Edendale, and 70% in
Pinetown), followed by ‘to prevent pregnancy’ (41% in Ladysmith,
66% in Edendale, and 52% in Pinetown), and ‘to protect myself
from STIs’ (29% in Ladysmith, 38% in Edendale, and 58% in
Pinetown). Protecting sexual partners from HIV or STIs was less
often mentioned in Ladysmith and Edendale, and rarely
mentioned in Pinetown (data not shown). The most common
reason for not using a condom was partner refusal (40% in
Ladysmith, 28% in Edendale, and 33% in Pinetown).
HIV prevalence
HIV prevalence was higher than 40% at all three CRCs: 42.0%
(95% CI 38.5, 45.5) in Ladysmith, 46.1% in Edendale (95% CI
43.1, 49.1), and 41.3% (95% CI 38.0, 44.6) in Pinetown. Factors
positively associated with prevalent HIV infection at all three
CRCs in age-adjusted and multivariable models were: age, lower
educational level, self-assessment of HIV risk as moderate or high
(compared to no or low risk), and suspected positive or unknown
HIV serostatus of a current sexual partner; no or inconsistent
condom use was associated with HIV infection in all age-adjusted
models but not in all multivariable models (Tables 2 and 3).
Having an income below 500 Rand per month, having more than
one sex partner in the last 3 months, and the presence of genital
symptoms at baseline were only associated with prevalent HIV in
Pinetown (Tables 2 and 3). Being married or living together and
oral sex were not associated with prevalent HIV.
HIV incidence
Overall HIV incidence rates based on seroconversions during
the 12-month follow-up period in the cohort studies were 14.8/
100 PY (95% CI 9.7, 19.8) in Ladysmith, 6.3/100 PY (95% CI
3.2, 9.4) in Edendale, and 7.2/100 PY (95% CI 3.7, 10.7) in
Pinetown (Table 3). No clear trends in incidence rates over time
could be discerned (Figure 1). Statistically significant predictors of
HIV seroconversion were not identified, most likely due to limited
statistical power, with the following exceptions: reporting 3 or
more sex partners in the last 3 months (compared to 1 or 2 sex
partners), and reporting genital symptoms at baseline, were
associated with HIV seroconversion in Edendale (data not shown).
The adjusted HIV incidence rates estimated by cross-sectional
BED testing are shown in Table 4.
Table 3. Determinants of Prevalent HIV Infection in the Cross-Sectional Studies – Multivariable Models.
Determinant Ladysmith (N=798) Edendale (N=1,084) Pinetown (N=891)
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Age (year) 1.12 (1.07, 1.17) 1.16 (1.12, 1.20) 1.13 (1.09, 1.18)
Highest level of education achieved:
Some/completed primary education 1.87 (0.59, 5.94) 12.77 (2.93, 55.66) 4.57 (1.50, 13.95)
Some/completed high school 1.92 (1.09, 3.40) 6.72 (2.02, 22.40) 3.21 (1.21, 8.53)
Some/completed tertiary education (reference)
Average monthly income
0-R500 (reference)
.R500 0.90 (0.59, 1.37) 1.46 (0.62, 3.41) 0.45 (0.26, 0.76)
Number of sex partners in last 3 months
1 (reference)
More than 1 1.95 (1.09, 3.50) 1.02 (0.58, 1.79) 1.27 (0.76, 2.12)
Condom use in last 7 days
Always (reference)
Inconsistent 1.89 (1.16, 3.07) 2.27 (1.39, 3.72) 1.24 (0.71, 2.16)
Never 1.27 (0.78, 2.06) 1.40 (0.96, 2.03) 1.07 (0.65, 1.76)
Self assessment of HIV risk
No/low risk (reference)
Moderate risk 2.72 (1.35, 5.46) 3.54 (2.29, 5.47) 2.29 (0.65, 8.04)
High risk 3.16 (2.10, 4.75) 3.15 (2.12, 4.67) 2.12 (1.32, 3.40)
Any chance that any current sex partner is HIV+
Yes 2.61 (1.55, 4.40) 2.90 (1.62, 5.21) 2.58 (1.33, 5.03)
Don’t know 2.36 (1.48, 3.78) 2.34 (1.46, 3.76) 1.56 (0.89, 2.72)
No (reference)
doi:10.1371/journal.pone.0035278.t003
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The pregnancy prevalence rates in the cross-sectional studies
were low at all three CRCs in accordance with the recruitment
strategy (only women reporting not to be pregnant were eligible
for study participation): 2.6% (95% CI 1.6, 4.0) in Ladysmith,
4.1% (95% CI 3.0, 5.4) in Edendale, and 1.5% (95% CI 0.8, 2.5)
in Pinetown. Pregnancy was associated with inconsistent condom
use (age-adjusted OR 3.5, 95% CI 1.1, 11.4) and self-reported
genital symptoms (age-adjusted OR 4.2, 95% CI 1.2, 15.2) in
Ladysmith, and with ‘never used condoms’ (age-adjusted OR 4.1
(95% CI 1.8, 9.7) and self-reported moderate or high HIV risk
(age-adjusted OR 3.7 (95% CI 1.5, 9.6) and 3.8 (95% CI 1.7, 8.8),
respectively) in Edendale. In the cohort studies, overall pregnancy
incidence for the 12-month period was 5.7 (95% CI 2.6, 8.7) in
Ladysmith, 3.1 (95% CI 0.9, 5.2) in Edendale, and 6.3 (95% CI
3.0, 9.6) in Pinetown. Again, no trends were observed over time
(Figure 2).
Discussion
Our data confirm that HIV prevalence and incidence continue
to be high in sexually active women aged 18–35 years living in
peri-urban areas of KwaZulu-Natal. Our prevalence rates are
similar to those reported in the 2009 and 2010 national antenatal
surveys but higher than those reported in the 2008 HSRC
population-based household survey (26% for women and men
combined and for all districts of KwaZulu-Natal combined) [3–5].
The latter is most likely due to the fact that the HIV prevalence is
higher in South African women than in men; unfortunately, only
aggregate data were reported [5]. Compared to women aged 20–
Figure 1. HIV incidence in the prospective cohort studies. Women enrolled in the 12-month cohort studies visited the CRC at 3, 6, 9, and 12
months after enrollment for HIV testing. HIV incidence rates were calculated based on a Poisson distribution with PY at risk in the denominator. They
are expressed as number of cases per 100 PY with 95% confidence intervals. HIV infection was assumed to have occurred at the mid-point between
the last available negative test and first positive test.
doi:10.1371/journal.pone.0035278.g001
Table 4. HIV and Pregnancy Incidence Rates in the Prospective Cohort Studies.
Ladysmith Edendale Pinetown
HIV incidence after 12 months 14.8 (9.7, 19.8) 6.3 (3.2, 9.4) 7.2 (3.7, 10.7)
HIV incidence in first 6 months 17.4 (10.3, 24.5) 5.5 (1.7, 9.3) 8.6 (3.5, 13.7)
HIV incidence in second 6 months 11.0 (4.2, 17.8) 7.3 (2.3, 12.4) 5.2 (0.6, 9.8)
HIV incidence BED adjusted (155 days; 1.7%) [17] 15.0 (10.1, 19.9) 10.2 (6.8, 13.7) 11.6 (7.6, 15.7)
HIV incidence BED adjusted (187 days; 1.7%) [17,18] 12.5 (8.4, 16.6) 8.5 (5.6, 11.4) 9.7 (6.3, 13.0)
Pregnancy incidence after 12 months 5.7 (2.6, 8.7) 3.1 (0.9, 5.2) 6.3 (3.0, 9.6)
Pregnancy incidence in first 6 months 7.4 (2.8, 12.0) 2.0 (0, 4.4) 7.0 (2.4, 11.6)
Pregnancy incidence in second 6 months 3.2 (0, 6.7) 4.4 (0.5, 8.3) 5.3 (0.7, 9.9)
doi:10.1371/journal.pone.0035278.t004
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study participants reported having had 2 or more partners in the
last 3 months (8–13% versus 4%) and a slightly lower proportion
reported condom use during the last sex act (47–62% versus 67%)
[5].
Our HIV incidence rates of 6.3 to 14.8 per 100 PY suggest that
HIV transmission is still rampant in KwaZulu-Natal. Our
incidence rates for Edendale (6.3/100 PY; uMgungundlovu
district) and Pinetown (7.2/100 PY; eThekwini district) fall within
the range of rates recently reported for urban and rural women in
eThekwini and uMkhanyakude districts (6.4/100 PY among
urban women and 6.5/100 PY among rural women aged 14–30
years [7] and 3.6/100 PY among rural women aged 15–55 [10]).
Our incidence rate for Ladysmith (14.8/100 PY; uThukela
district), however, was substantially higher than any of these rates
and we were not able to identify any reported incidence rates for
Ladysmith or uThukela district to compare ours to. The higher
incidence rate in Ladysmith cannot be explained by a higher HIV
prevalence. HIV prevalence in uThukela district was slightly
higher than in the other districts in 2009 but fell with almost 10%
to a relatively low level of 37% in 2010 [3,4]. We also found hardly
any significant differences in demographics (age, education and
marital status) and sexual behavior between the three study
populations. A higher proportion of women in Ladysmith had an
average monthly income higher than R500 than in the other two
study areas (32% versus 4 and 13%) but income was not associated
with HIV seroconversion. Data on male circumcision, alcohol use,
the presence of laboratory-confirmed sexually transmitted infec-
tions, and migration were not collected; temporary migration to
other urban areas (such as Johannesburg and Durban) for work
may fuel the HIV epidemic in Ladysmith more than in the other
districts. Furthermore, HIV incidence was particularly high in the
second quarter of the study, which is when recruitment in more
remote rural areas of uThukela district was initiated. This
population had not previously had access to high quality HIV
counseling and testing services.
As expected, HIV incidence rates based on the adjusted BED-
CEIA results were higher than those based on seroconversions per
100 PY for the two sites with lower HIV incidence (Edendale and
Pinetown; Table 4) [17,18]. However, the confidence intervals
overlap substantially for all three study sites.
While HIV incidence at the three study sites seems sufficiently
high for implementation of HIV microbicide efficacy trials,
retention rates would have to be improved (currently 43–70%)
and pregnancy incidence would have to be reduced. Women in
our studies were required to use a condom and a hormonal
method of contraception but the high pregnancy incidence rates
indicate that these methods were not used correctly and
consistently.
A few limitations of our data should be noted. The eligibility
criteria for study participation may have limited generalizability of
our results. The HIV prevalence rates apply only to young,
sexually active women who were not known to be HIV-infected or
pregnant, and who agreed to be tested regularly for HIV. The
total number of seroconversions in each prospective cohort study
were low (16–33 cases) and the 95% confidence intervals were
therefore wide. The low retention rates of our cohort studies (43–
70%) may have biased our HIV incidence estimates based on
seroconversions. We do not have any indications that the women
who left the cohort studies early were at higher or lower risk of
HIV acquisition than the women who remained in the study but
we cannot be certain. The 95% confidence intervals of the cross-
sectional BED-based HIV incidence estimates were also wide.
Furthermore, we did not measure local false-recent rates or
Figure 2. Pregnancy incidence in the prospective cohort studies. Urine pregnancy tests were done at each study visit (screening, enrollment,
and 3, 6, 9, and 12 months after enrollment in the cohort study). If test result was positive, the participant was to continue on study for follow-up per
protocol. Estimated date of conception and estimated due date were to be recorded. If possible, follow-up was to continue for pregnancy outcome.
Contraceptive counseling was provided and condoms were dispensed at each study visit.
doi:10.1371/journal.pone.0035278.g002
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as recommended by WHO [19].
In conclusion, HIV prevalence and incidence remain very high
in sexually active women living in peri-urban areas of KwaZulu-
Natal. HIV prevention interventions in these populations should
be strengthened.
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